Oral GLP-1 can be a clinically appropriate choice for the right patient
Fortunately, most are mild to moderate and tend to improve over time
Yet while reducing cardiovascular disease by treating high cholesterol, high blood pressure, and diabetes is standard practice, the concept of treating obesity to reduce cardiovascular complications has been hampered by the lack of evidence that lifestyle or pharmacologic interventions for overweight or obesity improve cardiovascular outcomes, said Michael Lincoff, M.D., SELECTs lead author and vice chair for research in Cleveland Clinics Department of Cardiovascular Medicine
She reflected on these changes across the last year in a post on Wednesday, posting a gym selfie and an affirmation that reads: I chose repair over resentment
doi:10.1038/nrrheum.2014.193 27 Prado CM et al.: Muscle matters: the effects of medically induced weight loss on skeletal muscle
This is a common side effect for most injectable treatments and should clear up in a few days